MyBlueDotsBioSkryb Genomics Launches ResolveSEQ MRD: A Next-Generation Measurable Residual Disease (MRD) Discovery Solution MyBlueDots4 months ago01 mins DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb launches ResolveSEQ MRD, an innovative service offering designed to empower further classification and characterization of MRD cells. Post navigation Previous: Instem Introduces Cloud-Hosted Non-GLP Pathology Module for ProvantisNext: RefleXion Launches Pivotal Study to Expand SCINTIX Therapy and Announces Broader Medicare Reimbursement
An overlooked cell type orchestrates brain rewiring during states of heightened attention MyBlueDots3 days ago 0
Violence between parents or in the community increases risk of child punishment MyBlueDots3 days ago 0
Genome mapping of Brazil’s diverse population uncovers new variants linked to health MyBlueDots3 days ago 0